✦ LIBER ✦

Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation

✍ Scribed by Schriber, J; Milk, B; Shaw, D; Christiansen, N; Baer, M; Slack, J; Tezcan, H; Wetzler, M; Herzig, G

Book ID: 110012306
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 41 KB
Volume: 24
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant tissue plasminogen activator

Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment

✍ Bajwa, R P S; Cant, A J; Abinun, M; Flood, T J; Hodges, S; Hale, J P; Skinner, R 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

Increased levels of tissue plasminogen a

Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNFα)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT)

✍ Ch. Seeber; E. Hiller; E. Holler; H.J. Kolb 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 794 KB

Recombinant tissue plasminogen activator

Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients

✍ Dr. Lolie C. Yu; Indrani Malkani; Oswaldo Regueira; David L. Ode; Raj P. Warrier 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

Epidural hematoma following tissue plasm

Epidural hematoma following tissue plasminogen activator (tPA) therapy for pulmonary embolism in a pediatric patient with stage IV Burkitt's lymphoma: A case report

✍ Patcharee Komvilaisak; Ronald Grant; Sheila Weitzman; Leonardo Brandao; Susan Bl 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 427 KB

Bone marrow transplantation for transfus

Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center

✍ Lucarelli, G; Angelucci, E; Polchi, P; Baronciani, D; Erer, B; Sotti, G; Gaziev, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 48 KB

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets